Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 1,410 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Hypertension
Interventions: Morning meal challenge, Evening meal challenge; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Peripheral Artery Disease, Endothelial Dysfunction, Autonomic Imbalance
Interventions: TVS, Sham TVS; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 85 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Human Immunodeficiency Virus, Coronary Artery Disease
Interventions: Evolocumab; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: AV Block, AV Block Complete, 3rd Degree Heart Block, Complete Heart Block
Interventions: Accelerometer Sensing for Micra AV Study; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 18
States / cities: Stockton, California • Jacksonville, Florida • Leesburg, Florida + 14 more

Conditions: Stroke, Acute Stroke
Interventions: Hip flexion soft exosuit, ReWalk ReStore soft exosuit, Conventional physical therapy; Device · Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 85 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mitral Valve Regurgitation (Degenerative or Functional)
Interventions: Edwards EVOQUE Eos Mitral Valve Replacement System; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: 18 Years and older
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2033
U.S. locations: 16
States / cities: Burlingame, California • Los Angeles, California • San Francisco, California + 13 more

Conditions: Peripheral Artery Disease
Interventions: VM202, Placebo; Drug · Other
Lead sponsor: Northwestern University; Other
Eligibility: 55 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Coronary Artery Disease, Ischemic Heart Disease (IHD), Myocardial Viability
Interventions: Not listed
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 20 Years to 80 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Brain Metastases, Adult, Neurocognitive Function, Cancer, Meningioma of Brain, Arteriovenous Malformations, Cerebral
Interventions: Cognitive Sparing Brain Stereotactic Radiosurgery (SRS); Radiation
Lead sponsor: Jona Hattangadi-Gluth; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Heart Failure, Diastolic
Interventions: PowerBreathe (Breathing muscle training); Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Diabetes, Hypertension, Hyperlipidemia
Interventions: Exercise, Reduced Calorie Diet, Weight Maintenance Diet; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 65 Years and older
Enrollment: 167 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Peripheral Artery Disease (PAD)
Interventions: Not listed
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Arlington, Texas

Conditions: Vascular Diseases
Interventions: Rhythmic Handgrip Exercise, Chronic Exercise Training; Other
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 90 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Hypertension
Interventions: CIN-107; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 2
States / cities: Orlando, Florida • Tampa, Florida

Conditions: Right Ventricular Dysfunction
Interventions: 3D TEE RVEF; Diagnostic Test
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cardiomyopathy, Renal Impairment
Interventions: Tadalafil, Placebo; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Coronary Artery Disease
Interventions: prasugrel, clopidogrel; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 2
States / cities: Jacksonville, Florida • Cincinnati, Ohio

Conditions: Stroke, Gait, Hemiplegic
Interventions: Exoskeleton mediated gait training, High intensity gait training; Behavioral
Lead sponsor: Alvernia University; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Allentown, Pennsylvania

Conditions: Cerebral Amyloid Angiopathy
Interventions: Ponezumab, placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 7
States / cities: Los Angeles, California • Boston, Massachusetts • Charlestown, Massachusetts + 2 more

Conditions: Congenital Heart Disease
Interventions: Treprostinil, Placebo; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Type 2 Diabetes
Interventions: Acipimox, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 30 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Echocardiography, Doppler
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Diseases
Interventions: No UPF controlled diet, High UPF controlled diet; Other
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 40 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Coronary Atherosclerosis, Coronary Artery Calcification, Coronary Stenosis
Interventions: Aged garlic extract and Coenzyme Q10; Dietary Supplement
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 35 Years to 84 Years · Male only
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Torrance, California

Search by objective public record fields.

Chronobiology of Meal Timing: Effects on Vascular and Renal Function

Effect of Transcutaneous Vagal Stimulation (TVS) on Endothelial Function in PAD

Effect of Evolocumab on Coronary Endothelial Function

Accelerometer Sensing for Micra AV Study

Soft Exosuits for Functional Gait Recovery in Acute Stroke Rehabilitation

Edwards EVOQUE Eos MISCEND Study

Hepatocyte Growth Factor to Improve Functioning in PAD

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions

Respiratory Muscle Function in Heart Failure

Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults

Using Near-Infrared Light to Better Understand Peripheral Artery Disease

Autophagy Maintains Vascular Function Through a Novel Glycolysis-linked Pathway Regulating eNOS

Study to Evaluate the Pharmacokinetics of CIN-107 in Subjects With Varying Degrees of Renal Function

TEE 3D RV Assessment for SAVR, Mini AVR, and TAVR

Study to Determine How Cialis Effects the Renal Function in Response to Volume Expansion in Preclinical Systolic Cardiomyopathy (Aim2)

Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease

Comparing Effects of Conventional Neurorehabilitation With Exoskeleton With High-intensity Gait Training

Study Evaluating the Safety,Tolerability and Efficacy of PF-04360365 in Adults With Probable Cerebral Amyloid Angiopathy

Acute Effects of Inhaled Treprostinil in Fontan Patients

Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

Technical Development of Strain Rate Echocardiography

Highly Processed Foods and Vascular Health

Firefighter Aged Garlic Extract Investigation With CoQ10 as a Treatment for Heart Disease (FAITH)